Sr Manager, Market Access at Gilead Sciences

Bogota, D.C., Bogota, D.C., Colombia

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Robust and demonstrable experience in developing, implementing and delivery of market access and health economic strategies and materials
Solid understanding of Market Access processes and payer needs and strategies
Affinity and solid understanding of pricing dynamics that impact the Gilead portfolio, and drive to raise the bar on current practices
Demonstrates accountability, a mindset that works through uncertainty, delivers to expectations and exhibits a sense of urgency on critical time-dependent issues
Capability to network, build strong and credible relationships with internal colleagues and payer stakeholders
Strong teamwork and facilitation, effective working in matrix environment and managing cross functional responsibilities
Ability to seamlessly bridge strategic vision with operational execution, ensuring alignment between long-term objectives and on-the-ground implementation
At least 5 years’ experience in relevant field

Responsibilities

Lead the market access, reimbursement and EPS access strategies for Gilead Portfolio in collaboration with external and internal partners
Engage and leverage network with EPS and other relevant market access stakeholders at operational and decision-making levels to address coding, portfolio monitoring within the EPS, manage tenders, or any information needs that ensure the positioning of Gilead's portfolio within the EPS
Identify and address market access barriers for Gilead portfolio at all levels of the EPS and resolve them
Work together with the Brand teams of Virology and Oncology to develop compelling value propositions, access strategies and appropriate tools that enable access solutions which result in outcomes benefiting patients and Gilead, understanding the different payer archetypes and its ecosystems
Support the field team in presenting pharmacoeconomic results, economic models, and value messaging for Gilead’s strategic portfolio products
Lead and implement pricing strategies and initiatives as well as innovative agreements with EPS in alignment with local procedures and consistent with the global pricing strategy
Establish working relationships with all relevant functions across Gilead, providing strategic inputs for the development of the overall brand strategy and delivery of robust plan of action for all cross-functional stakeholders
Support the development of account plans with the cross functional teams in key accounts to maximize and ensure access for Gilead products
Strategically co-lead with the Government Affairs lead the analysis and leadership-level discussions on changes in the Colombian healthcare system, assessing their potential impact on Gilead’s portfolio positioning and market strategy

Skills

Market Access

Reimbursement

EPS Strategies

Stakeholder Engagement

Value Propositions

Access Strategies

Portfolio Management

Tenders

Coding

Virology

Oncology

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free